Status:
COMPLETED
Sleep, Rhythms and Risk of Alzheimer's Disease
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Alzheimer Disease
Sleep
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Alterations in sleep and the sleep / wake cycle, which are particularly common in Alzheimer's disease patients, could represent an early biomarker for cognitive decline and onset of dementia . Moreove...
Eligibility Criteria
Inclusion
- Belonging to AMImage 2 cohort and preferentially belonging to subjects included in the first actimetric assessment. AMI subjects have been selected based on Mutualité Sociale Agricole of Gironde (agricultural Health Insurance system database as followed :
- \>65 years old
- Retired from agriculture
- Living in Gironde countryside
- Being affiliated to the French Farmers Health Insurance
- Signed Informed Consent
Exclusion
- Left Handed subjects
- Severe dementia (MMSE\<13)
- Stroke
- Parkinson's disease
- MRI contraindication
- Health state not allowing displacement to the hospital
- Person under gardianship and not able to give its informed consent
Key Trial Info
Start Date :
September 9 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 22 2022
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT04044495
Start Date
September 9 2019
End Date
February 22 2022
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Bordeaux
Bordeaux, France, 33 076